IREN lacks a near-term catalyst strong enough to drive a real move to new highs, yet this is a level to buy, not sell. IREN's Dan Roberts suggested deals should not be expected soon, and anything short of a deal likely brings only a small pop and fade. The risk is subpar November earnings and no deal before February results, since the chart cannot afford a five-month fade. x.com x.com x.com x.comÂ